Organization
InflaRx
4 clinical trials
Clinical trial
A Pragmatic Adaptive Randomized, Controlled Phase II/III Multicenter Study of IFX-1 in Patients With Severe COVID-19 PneumoniaStatus: Completed, Estimated PCD: 2021-10-31
Clinical trial
Open Label Exploratory Phase IIa Trial to Investigate the Safety and Efficacy of IFX-1 in Treating Patients With Pyoderma Gangrenosum (OPTIMA)Status: Completed, Estimated PCD: 2022-01-03
Clinical trial
Open Label, Multicenter Phase II Study of the C5a Antibody IFX-1 Alone or IFX-1 + Pembrolizumab in Patients With PD-1 or PD-L1 Resistant/Refractory Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (cSCC)Status: Active (not recruiting), Estimated PCD: 2024-06-30
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Multicenter, Adaptive Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in the Treatment of Ulcerative Pyoderma GangrenosumStatus: Recruiting, Estimated PCD: 2026-02-13